Fig. 1From: Low WT1 transcript levels at diagnosis predicted poor outcomes of acute myeloid leukemia patients with t(8;21) who received chemotherapy or allogeneic hematopoietic stem cell transplantationPatients with a cellular homolog of the viral oncogene v-KIT receptor tyrosine kinase (C-KIT) mutation had significantly lower Wilm tumor gene-1 (WT1) transcript levels at diagnosis than patients who did not have a C-KIT mutation. Line represents median WT1 transcript levelsBack to article page